Background. Staging for lung cancer based on the TNM classification is an i
mportant predictive factor for prognosis. Recently, lung cancer with ipsila
teral intrapulmonary metastasis (PM) was reclassified according to the revi
sion of the TNM classification. To evaluate the prognostic importance of th
e new staging system for PM, we analyzed the postoperative survival of pati
ents with non-small cell lung carcinoma.
Methods. Of 1,002 consecutive patients who underwent operation for primary
lung cancer between Tune 1984 and December 1996, we reviewed the medical re
cord of 889 patients who underwent complete resection for nonsmall cell lun
g cancer.
Results. We considered 89 patients (10.0%) to have synchronous ipsilateral
PM. After reclassification to the former staging system revised in 1995 5 p
atients were classified as stage I, 29 as stage IIIA, 48 as stage IIIB, and
7 as stage IV. In the new staging system revised in 1997, 48 patients were
recategorized as stage IIIB, and 41 as stage TV. The 5-year survival of pa
tients without PM (49.5%) was significantly better than that of patients wi
th PM in primary-tumor lobe (29.6%, p = 0.002) or in nonprimary-tumor ipsil
ateral lobe (23.4%, p = 0.0002). Although the survival of patients with sta
ge IV cancer without PM was significantly worse than that of patients with
the new (1997) stage IV cancer with PM (p = 0.02), it was similar to that o
f patients with the former (1992) stage IV cancer with PM. The survival of
PM patients with N0 or N1 disease was significantly better than that of PM
patients with N2 or N3 disease (p = 0.001). Furthermore, in patients with t
he new (1997) stage IIIB cancer, the survival of N0 disease was better than
that of N2 disease (p = 0.007).
Conclusions. Inasmuch as the prognosis of non-small cell carcinoma in patie
nts with PM strongly correlated with N factor rather than PM factor, N fact
or should be reflected in a staging designation. We therefore consider the
new TNM classification for PM reclassified in 1997 to be less acceptable fo
r surgical-pathologic staging than the revision in 1992. (C) 1999 by The So
ciety of Thoracic Surgeons.